Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Novel Approaches to Secondary Prevention of Thrombotic Events in Peripheral Arterial Disease

Access Activity

Overview / Abstract:

This enduring activity shares highlights from a live presentation at the 16th Annual New Cardiovascular Horizons (NCVH) Conference in New Orleans on Friday, May 29, 2015.

Dr. Craig Walker and Dr. Pierluigi Tricoci discuss the atherothrombotic burden of PAD and the use of newer antiplatelet therapies for secondary prevention of CVD events in patients with PAD. The didactic content is supplemented by discussion of several case presentations.

Peripheral arterial disease (PAD), an independent predictor of cardiovascular disease (CVD) morbidity and mortality, is associated with increased hospitalization costs, recurrent hospitalizations, and repeat revascularizations. Overall, patients with PAD have higher 1-year and 3-year hospitalization rates for vascular causes than those with other CVD. Adherence to guideline-recommended approaches, including antiplatelet therapy, significantly reduces the rates of major adverse limb events, major adverse cardiac events, and all-cause mortality. Select patient populations may require alternative and aggressive antiplatelet strategies to reduce recurrent events and rehospitalizations. This interactive activity will address selection of approaches to platelet inhibition for secondary prevention of CVD events in the PAD patient.

Upon completion of this activity, participants will be able to:
• Outline the burden and risks of atherothrombotic events in patients with PAD
• Review the mechanisms of action of antiplatelet therapies for optimal postsurgical management of PAD
• Compare and contrast strategies for secondary prevention via platelet inhibition to reduce risks of PAD and CVD

Expiration

Jul 30, 2016

Discipline(s)

Education (Higher Ed) , EMS / EMT / Paramedic CE, Nurse Practitioner , Nursing CNE, Occupational Therapy CE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE, Surgical Technology CE

Format

New Procedures, Online, Podcast, Webinar / Webcast / Video

Credits / Hours

The Academy for Continued Healthcare Learning designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Accreditation

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Is This Activity Certified for "Live" Credit?

YES

Presenters / Authors / Faculty

Craig M. Walker, MD, FACC, FACA, FACP, FSCAI, FASCI, FCCP, FICA
Founder, President and Medical Director,
Cardiovascular Institute of the South
Clinical Professor of Medicine
Tulane University School of Medicine
LSU School of Medicine
New Orleans, Louisiana

Pierluigi Tricoci, MD, PhD, MHS
Assistant Professor of Medicine, Cardiology
Duke University School of Medicine
Durham, North Carolina

Activity Specialities / Related Topics

Cardiology / Cardiovascular, Diagnosis / Assessment / Patient History, Education / Teaching, Emergency Medicine, Internal Medicine, Podiatry, Preventive Care, Primary Care, Surgery, Wound Care

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Merck & Company

Keywords / Search Terms

ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Webcasts, PAD, vorapaxar, zontivity, peripheral arterial disease, NCVH, new cardiovascular horizons, Dr. Walker, craig walker, pierluigi tricoci, Dr. Tricoci, secondary prevention of PAD, atherothrombotic events, postsurgical management of PAD, Merck CME, antiplatelets, antiplatelet therapy Free CE CME Live CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map